All Stories

Atalanta laces up for clinic after RNA epilepsy candidate suppresses seizures in mice

Big Pharma-backed Atalanta Therapeutics is ramping up for the clinical debut of the company’s lead epilepsy asset with new data showing the RNA therapy suppressed seizures in mice.

Apr 10, 2025 - 10:31
 0
Atalanta laces up for clinic after RNA epilepsy candidate suppresses seizures in mice
Big Pharma-backed Atalanta Therapeutics is ramping up for the clinical debut of the company’s lead epilepsy asset with new data showing the RNA therapy suppressed seizures in mice.
Read More

Tags:

Previous Article

Xpeng opens first Scottish dealership as rollout accelerates

Next Article

Comparing fashion’s carbon emissions to earnings in 5 charts

Related Posts

Apollomics tags out of TYG oncology pact to cut costs, extend runway into 2026

Apollomics tags out of TYG oncology pact to cut costs, ...

Apr 4, 2025  0

Arbor sails into rocky gene editing waters with $74M for rare liver disease therapy

Arbor sails into rocky gene editing waters with $74M fo...

Mar 18, 2025  0

Samsung backs Alzheimer's blood test developer C2N Diagnostics with $10M

Samsung backs Alzheimer's blood test developer C2N Diag...

Mar 13, 2025  0